Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Neurocrine_Biosciences> ?p ?o. }
Showing items 1 to 62 of
62
with 100 items per page.
- Neurocrine_Biosciences abstract "Neurocrine Biosciences is a biopharmaceutical company founded in 1992 and located in San Diego, California. The company tooks its name from the original focus on therapies for neurological and endocrine diseases and disorders.The company endured a significant setback on May 16, 2006 when the Food and Drug Administration (FDA) denied approval for the 15-milligram dose of Indiplon, a medication to treat insomnia. Neurocrine had developed the drug and was seeking to market it with partner, Pfizer. Announcement of the setback led to a 62% drop in stock price. Subsequent disclosures related to attempts to overcome this major setback caused a further drop in the stock by 30% in November 2006.Lacking approval for Indiplon, the company laid off a 200-member sales force in July, 2006 and 100 employees across all areas of the company on August 7, 2006. It announced a further cut of half the remaining workforce in December 2007, and a fourth quarter loss of $128 million, including a $94 million write-off.But recently the company has recovered the long term hope for recovery. All started on the 25th of May, 2010 when the shares jumped nearly 25% after the company announced its drug to treat endometriosis had achieved its main and secondary goals in a study.The drug, called elagolix, reportedly showed statistically significant reductions in dysmenorrhea, or pelvic pain during menstruation as well as painful intercourse. And the shares of the company were up 69 cents to $3.40 on May the 25th trading, hitting a 52-week high of $4.23 early in the trading session.But since that the stock has climbed from $4.23 to $6.16 at 25 June 2010. And the expectatives for NBIX has raised about the elagolix trial success and of the sign for development deal with Boehringer. and Abbott Laboratories.".
- Neurocrine_Biosciences foundingYear "1992".
- Neurocrine_Biosciences industry Biotechnology.
- Neurocrine_Biosciences keyPerson Gary_A._Lyons.
- Neurocrine_Biosciences keyPerson Joseph_A._Mollica.
- Neurocrine_Biosciences location California.
- Neurocrine_Biosciences location San_Diego.
- Neurocrine_Biosciences location United_States.
- Neurocrine_Biosciences numberOfEmployees "65".
- Neurocrine_Biosciences type Public_company.
- Neurocrine_Biosciences wikiPageExternalLink www.neurocrine.com.
- Neurocrine_Biosciences wikiPageID "5249173".
- Neurocrine_Biosciences wikiPageRevisionID "535362050".
- Neurocrine_Biosciences companyLogo "220".
- Neurocrine_Biosciences companyName "Neurocrine Biosciences".
- Neurocrine_Biosciences companyType "Public".
- Neurocrine_Biosciences foundation "1992".
- Neurocrine_Biosciences hasPhotoCollection Neurocrine_Biosciences.
- Neurocrine_Biosciences homepage www.neurocrine.com.
- Neurocrine_Biosciences industry Biotechnology.
- Neurocrine_Biosciences keyPeople "Gary A. Lyons, CEO/President".
- Neurocrine_Biosciences keyPeople "Joseph A. Mollica, Chairman".
- Neurocrine_Biosciences location California.
- Neurocrine_Biosciences location San_Diego.
- Neurocrine_Biosciences location United_States.
- Neurocrine_Biosciences numEmployees "65".
- Neurocrine_Biosciences wordnet_type synset-company-noun-1.
- Neurocrine_Biosciences subject Category:Biotechnology_companies_of_the_United_States.
- Neurocrine_Biosciences subject Category:Companies_based_in_San_Diego,_California.
- Neurocrine_Biosciences subject Category:Companies_established_in_1992.
- Neurocrine_Biosciences subject Category:Companies_in_the_NASDAQ_Biotechnology_Index.
- Neurocrine_Biosciences type Abstraction100002137.
- Neurocrine_Biosciences type BiotechnologyCompanies.
- Neurocrine_Biosciences type CompaniesBasedInSanDiego,California.
- Neurocrine_Biosciences type CompaniesInTheNASDAQBiotechnologyIndex.
- Neurocrine_Biosciences type CompaniesListedOnNASDAQ.
- Neurocrine_Biosciences type Company108058098.
- Neurocrine_Biosciences type Group100031264.
- Neurocrine_Biosciences type Institution108053576.
- Neurocrine_Biosciences type Organization108008335.
- Neurocrine_Biosciences type SocialGroup107950920.
- Neurocrine_Biosciences type YagoLegalActor.
- Neurocrine_Biosciences type YagoLegalActorGeo.
- Neurocrine_Biosciences type YagoPermanentlyLocatedEntity.
- Neurocrine_Biosciences type Agent.
- Neurocrine_Biosciences type Company.
- Neurocrine_Biosciences type Organisation.
- Neurocrine_Biosciences type Organization.
- Neurocrine_Biosciences type Agent.
- Neurocrine_Biosciences type SocialPerson.
- Neurocrine_Biosciences type Thing.
- Neurocrine_Biosciences comment "Neurocrine Biosciences is a biopharmaceutical company founded in 1992 and located in San Diego, California. The company tooks its name from the original focus on therapies for neurological and endocrine diseases and disorders.The company endured a significant setback on May 16, 2006 when the Food and Drug Administration (FDA) denied approval for the 15-milligram dose of Indiplon, a medication to treat insomnia. Neurocrine had developed the drug and was seeking to market it with partner, Pfizer.".
- Neurocrine_Biosciences label "Neurocrine Biosciences".
- Neurocrine_Biosciences sameAs m.0d9x5t.
- Neurocrine_Biosciences sameAs Mx4rvmyhiJwpEbGdrcN5Y29ycA.
- Neurocrine_Biosciences sameAs Q7002174.
- Neurocrine_Biosciences sameAs Q7002174.
- Neurocrine_Biosciences sameAs Neurocrine_Biosciences.
- Neurocrine_Biosciences wasDerivedFrom Neurocrine_Biosciences?oldid=535362050.
- Neurocrine_Biosciences homepage www.neurocrine.com.
- Neurocrine_Biosciences isPrimaryTopicOf Neurocrine_Biosciences.
- Neurocrine_Biosciences name "Neurocrine Biosciences".